Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2012-11-30
2032-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PREFER-FERTILITY aims to obtain and centralize data about the preferences and choices of young cancer patients on the fertility preservation strategies available in Italy. Furthermore, it aims to assess the outcomes of patients undergoing one or more strategies for fertility preservation in terms of success of the techniques (i.e. recovery of ovarian function, number of cryopreserved oocytes, post-treatment pregnancies) and safety (i.e. long-term survival outcomes).
PREFER-PREGNANCY has two main objectives: 1) to obtain and centralize data on the management of breast cancer diagnosed during pregnancy, the obstetrical and paediatric care of children born after prior in utero exposure to anticancer treatments, and the long-term survival outcomes of these patients; 2) to obtain and centralize data on the clinical outcomes of breast cancer survivors that achieve a pregnancy after prior diagnosis and treatment of breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749
Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
NCT02284581
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
NCT05772390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between18 and 45 years (only for PREFER-FERTILITY)
* have not received any radiation or chemotherapy for cancer before enrolment (only for PREFER-FERTILITY)
* absence of metastatic disease (only for PREFER-FERTILITY)
* diagnosis of breast cancer during pregnancy or within 1 year from the end of pregnancy or pregnancy after prior diagnosis and treatment for breast cancer (only for PREFER-PREGNANCY)
* informed consent
Exclusion Criteria
* stage IV disease at diagnosis (only for PREFER-FERTILITY)
* serious psychiatric disorders
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Research Technology S.r.l.
INDUSTRY
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lucia Del Mastro,MD
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Presidio Ospedaliero 'Antonio Perrino'
Brindisi, BR, Italy
AOU di Cagliari Strada
Monserrato, Cagliari, Italy
Azienda Ospedaliera S. Croce e Carle
Cuneo, CN, Italy
Arcispedale S. Anna - A.O.U. di Ferrara
Cona, FE, Italy
Irccs Aou San Martino - Ist
Genoa, GE, Italy
Ospedale Vito Fazzi
Lecce, LE, Italy
Ospedale Unico Versilia
Lido di Camaiore, LU, Italy
Azienda Ospedaliera Carlo Poma
Mantova, MN, Italy
Ospedale 'Guglielmo da Saliceto'
Piacenza, PC, Italy
Fondazione S. Maugeri IRCCS
Pavia, PV, Italy
Azienda Ospedaliera S. Carlo
Potenza, PZ, Italy
Istituto Regina Elena per lo studio e la cura dei tumori
Roma, RM, Italy
Azienda Ospedaliera n. 1 - Annunziata
Sassari, SS, Italy
Fondazione del Piemonte per l'Oncologia - IRCC di Candiolo
Candiolo, TO, Italy
AOU SM Misericordia
Udine, UD, Italy
Ospedale Sacro Cuore Don Calabria
Negrar, VE, Italy
Ospedale Cardinal Massaia
Asti, , Italy
A.O.U. Federico II
Napoli, , Italy
Istituto Nazionale dei Tumori - Fondazione G.Pascale
Napoli, , Italy
Ospedale Santa Maria della Misericordia
Perugia, , Italy
AOU Pisana - Ospedale S. Chiara
Pisa, , Italy
Arcispedale Santa Maria Nuova di Reggio Emilia
Reggio Emilia, , Italy
ASS1 Triestina
Trieste, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Maria Giovanna Cavazzini, MD
Role: primary
Domenico Bilancia, MD
Role: primary
Fabio Puglisi
Role: primary
Testore
Role: primary
Crinò
Role: primary
Michelotti
Role: primary
La Sala
Role: primary
Ceccherini
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lambertini M, Anserini P, Fontana V, Poggio F, Iacono G, Abate A, Levaggi A, Miglietta L, Bighin C, Giraudi S, D'Alonzo A, Blondeaux E, Buffi D, Campone F, Merlo DF, Del Mastro L. The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients. BMC Cancer. 2017 May 19;17(1):346. doi: 10.1186/s12885-017-3348-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001377;000650
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.